yl23455永利官网

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR1900025889】The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study

    基本信息
    登记号

    ChiCTR1900025889

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2019-09-12

    临床申请受理号

    /

    靶点

    /

    适应症

    帕金森氏病

    试验通俗题目

    The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study

    试验专业题目

    The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    To evaluate the effect of traditional Chinese medicine tuina in treating the non-motor symptoms of Parkinson's Disease.

    试验分类
    试验类型

    随机平行对照

    试验分期

    探索性研究/预试验

    随机化

    This procedure is conducted by Mr Lai Hong Yi Justin, who is an individual research assistant. Each participant will receive a number randomly. Then, they will be randomly assigned into treatment group and control group by an Excel programme.

    盲法

    Assessor blinding (1) Assessor blinding: Assessor will receive the number sequence of participant. Assessor will never know the identity of participant or which group he/she belong to.

    试验项目经费来源

    No funding

    试验范围

    /

    目标入组人数

    30

    实际入组人数

    /

    第一例入组时间

    2019-10-21

    试验终止时间

    2020-03-31

    是否属于一致性

    /

    入选标准

    (1) clinical diagnosis of PD based on the criteria of United Kingdom Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (UKPDBB); (2) aged between 18 and 80 years old; (3) treatment with antiparkinsonian drugs (such as levodopa), stable over the previous two months; and (4) able to speak and understand Cantonese.；

    排除标准

    (1) Atypical or secondary parkinsonism; (2) Use of antidepressants during the preceding month; (3) History of psychosis; (4) Suicide attempts during the preceding 12 months; (5) Severe diseases (i.e. cancer, stroke and acute present heart attack); (6) Participating in other behavioural or pharmacological studies; (7) Pregnancy or beast feeding; (8) Surgery within preceding two months or having a scheduled operation within the period of study; or (9) Hoehn and Yahr (H&Y) stage ≧4, with activities limited to wheelchairs.；

    研究者信息
    研究负责人姓名
    试验机构

    香港浸會大學道賽馬會中醫藥學院

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    香港浸會大學道賽馬會中醫藥學院的其他临床试验

    更多

    最新临床资讯